• Skip to content
  • Accessibility help
Skip to content
Sign in
  • Guidance
  • Standards and indicators
  • Clinical Knowledge Summaries (CKS)
  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • Life sciences
  • Skip More from NICE submenu

    Explore more from NICE

    • What NICE does
    • About us
    • Reusing our content
    • Implementing NICE guidance
    • News, blogs and podcasts
    • Contact us
    • Get involved
    • Careers

    • Join a committee
    • Comment on a consultation

My account

  • Consultation responses
  • Sign in

You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Chronic liver disease

Seladelpar for previously treated primary biliary cholangitis [ID6429]

  • In development
  • Reference number: GID-TA11540
  • Expected publication date:  05 November 2025
  • Project information
  • Project documents
  • Consultation

On this page

  1. Draft guidance
  2. Invitation to participate
  3. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6429

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft guidance (downloadable version) (PDF 232 KB)

    Published:
    30 July 2025
  • Draft guidance (online commenting)

  • Committee papers (PDF 9.51 MB)

    Published:
    30 July 2025
  • Public committee slides (PDF 713 KB)

    Published:
    30 July 2025
  • Equality impact assessment (downloadable version) (PDF 133 KB)

    Published:
    30 July 2025
  • Final scope (PDF 141 KB)

    Published:
    30 July 2025

Invitation to participate

  • Final scope (PDF 138 KB)

    Published:
    19 November 2024
  • Final stakeholder list (PDF 132 KB)

    Published:
    19 November 2024
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 136 KB)

    Published:
    19 November 2024
  • Equality impact assessment (scoping) (PDF 100 KB)

    Published:
    19 November 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6429

  • Draft matrix post referral (PDF 176 KB)

    Published:
    03 September 2024
  • Draft scope post referral (PDF 202 KB)

    Published:
    03 September 2024
Back to top
  • Guidance
  • Standards and indicators
  • Clinical Knowledge Summaries (CKS) Clinical Knowledge SummariesClinical Knowledge Summaries
  • British National Formulary (BNF) British National FormularyBritish National Formulary
  • British National Formulary for Children (BNFC) British National Formulary for ChildrenBritish National Formulary for Children
  • Life sciences
  • Library and knowledge services
  • What NICE does
  • Implementing NICE guidance
  • Get involved
  • About us
  • Careers
  • News, blogs and podcasts
  • Newsletters and alerts
  • Contact us
  • Leave feedback
  • Reusing our content
  • NICE UK Open Content Licence
  • Syndicate our content
  • Events
  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Accessibility
  • Freedom of information
  • Glossary
  • Terms and conditions
  • Privacy notice
  • Cookies

© NICE 2025. All rights reserved. Subject to Notice of rights.